Minoxidil for alopecia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 5 Jun 2023: Trial registered, NCT05888922
  2. 17 Oct 2024: Trial started, NCT05888922

The trials

NCT05888922: Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

State
Under way
Phase
Phase 3
People
520 planned
Started
17 Oct 2024
Primary completion
Oct 2026
Arms
Active group
Results
None posted
  1. 5 Jun 2023: Trial registered
  2. 17 Oct 2024: Trial started

NCT07018349: Low Dose Oral Minoxdil in Androgenic Alopecia

State
Not started
Phase
No phase
People
76 planned
Started
15 Jun 2025
Primary completion
30 Sep 2025
Arms
Oral Minoxidil 2.5% mg, Oral Minoxidil 1% mg
Results
None posted
  1. 12 Jun 2025: Trial registered

NCT07529977: Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

State
Not started
Phase
Phase 3
People
372 planned
Started
31 Jan 2027
Primary completion
30 Oct 2028
Arms
N1087
Results
None posted
  1. 14 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as 1% Oral Minoxidil, 2.5% Oral minoxidil, Alopexil, Alostil, Loniten, Lonolox, Minodyl, Minoximen, Mintop, Normoxidil, Pierminox, Prexidil, Riup, Rogaine, Theroxidil, Tricoxidil, oral minoxidil.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.